About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[8] 51, 97, 98, 160, 162, 222, 300, 306 💬

Disease ID	Name
51	Scleroderma
97	Ulcerative colitis
98	Eosinophilic gastro-intestinal disorder
160	Congenital ichthyosis
162	Pemphigoid
222	Primary nephrotic syndrome
300	IgG4-related disease
306	Eosinophilic sinusitis

2

Dupilumab (blinded)

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 98 💬

3

Dupilumab (open-label)

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 98 💬

4

Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 98 💬

5

Dupilumab 300Mg Solution for Injection

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 51 💬

6

Dupilumab Injection

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 160 💬

7

Dupilumab open label extension phase

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 222 💬

8

Dupilumab Prefilled Syringe

[1] Dupilumab (Dupilumab)

[1] Dupilumab (Dupilumab) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 160 💬

9

Secukinumab was administered in a weight-adapted dosing regimen ? Dupilumab was administered at a dose dependent on the patient's weight and age

[2] Dupilumab (Dupilumab),
Secukinumab

[2] Secukinumab ,
Dupilumab (Dupilumab) 💬

[2] IL17A,
IL4R 💬

[11] Alcoholic liver disease, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 160 💬